BETADINE Drug Patent Profile
✉ Email this page to a colleague
When do Betadine patents expire, and when can generic versions of Betadine launch?
Betadine is a drug marketed by Alcon Pharms Ltd and is included in one NDA.
The generic ingredient in BETADINE is povidone-iodine. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the povidone-iodine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BETADINE?
- What are the global sales for BETADINE?
- What is Average Wholesale Price for BETADINE?
Summary for BETADINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 71 |
| Patent Applications: | 5,070 |
| Drug Prices: | Drug price information for BETADINE |
| What excipients (inactive ingredients) are in BETADINE? | BETADINE excipients list |
| DailyMed Link: | BETADINE at DailyMed |
Recent Clinical Trials for BETADINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The University of The West Indies | Early Phase 1 |
| Next Science LLC | Phase 4 |
| St. Louis University | Phase 4 |
US Patents and Regulatory Information for BETADINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Pharms Ltd | BETADINE | povidone-iodine | SOLUTION/DROPS;OPHTHALMIC | 018634-001 | Dec 17, 1986 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
